Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Power and Promise of Next-Generation Sequencing in Liquid Biopsies and Cancer Control.

Cancer control : journal of the Moffitt Cancer Center - 1 Jan 2000

Wu Ting-Miao, Liu Ji-Bin, Liu Yu, Shi Yi, Li Wen, Wang Gao-Ren, Ma Yu-Shui, Fu Da

Abstract excerpt

Traditional methods of cancer treatment are usually based on the morphological and histological diagnosis of tumors, and they are not optimized according to the specific situation. Precision medicine adjusts the existing treatment regimen based on the patient's genomic information to make it most suitable for patients. Detection of genetic mutations in tumors is the basis of precise cancer medicine. Through the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell-Free Nucleic Acids
Share to High-Throughput Nucleotide Sequencing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunotherapy

Share to Immunotherapy, Adoptive

Share to Liquid Biopsy

Share to Molecular Targeted Therapy

Share to Neoplasms

Share to Precision Medicine

Source

Open in PubMed Open full text

Identifiers

PMID: 32806937
DOI: 10.1177/1073274820934805
PMCID: PMC7791471

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Power and Promise of Next-Generation Sequencing in Liquid Biopsies and Cancer Control.PMID 32806937Read ↗

Application of next-generation sequencing technology to precision medicine in cancer: joint consensus of the Tumor Biomarker Committee of the Chinese Society of Clinical OncologySemantic proximity Read ↗

Next-generation sequencing in cancer diagnosis and treatment: clinical applications and future directionsSemantic proximity Read ↗

Next-generation sequencing to guide cancer therapySemantic proximity Read ↗

Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer.Semantic proximity Read ↗

Liquid Biopsy: Approaches to Dynamic Genotyping in CancerSemantic proximity Read ↗

Liquid biopsy: current technology and clinical applicationsSemantic proximity Read ↗

Liquid Biopsy in the Clinical Management of CancersSemantic proximity Read ↗

Liquid Biopsy, ctDNA Diagnosis through NGSSemantic proximity Read ↗

Liquid Biopsy: The Unique Test for Chasing the Genetics of Solid TumorsSemantic proximity Read ↗

The emerging roles of NGS-based liquid biopsy in non-small cell lung cancerSemantic proximity Read ↗

Cancer treatment comes to age: from one-size-fits-all to next-generation sequencing (NGS) technologiesSemantic proximity Read ↗

Molecular Testing for Diagnostics, Prognostication, and Treatment Stratification in Cancers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.